Cornerstone Advisors (Washington)’s Loxo Oncology, Inc LOXO Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-387	Closed	-$54K	–	1415
2018 Q4	$54K	Buy	387 +122	+46%	+$18.5K	0.01%	284
2018 Q3	$45K	Hold	265	–	–	0.03%	338
2018 Q2	$46K	Sell	265 -65	-20%	-$9.77K	0.03%	319
2018 Q1	$38K	Hold	330	–	–	0.03%	354
2017 Q4	$28K	Buy	+330	New	+$27.5K	0.02%	414

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Cornerstone Advisors (Washington)'s LOXO Position: Q1 2019 in Review

Cornerstone Advisors (Washington) sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 387 shares — an estimated $54K sold.

Cornerstone Advisors (Washington) first reported a position in LOXO in Q4 2017 and held it in 5 quarters. The position peaked at $54K in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Cornerstone Advisors (Washington) reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Cornerstone Advisors (Washington) sold 387 Loxo Oncology, Inc shares in Q1 2019, an estimated $54K.
Cornerstone Advisors (Washington) first reported a position in Loxo Oncology, Inc in Q4 2017 and held it in 5 quarters.
Cornerstone Advisors (Washington)'s Loxo Oncology, Inc position peaked at $54K in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q1 2019, filed 2 May 2019.